Literature DB >> 1701482

Identification of seroreactive regions of the human papillomavirus type 16 protein E4, E6, E7 and L1.

M Müller1, H Gausepohl, G de Martynoff, R Frank, R Brasseur, L Gissmann.   

Abstract

Small fragments of the DNA of human papillomavirus type 16 (HPV-16) were randomly cloned into the bacteriophage fd which expresses the resulting peptides as part of its capsid. Antisera raised against different HPV-16 fusion proteins were used for screening of the phage clones and the reacting peptides were determined by sequencing the inserted HPV-16 DNA fragments of the positive recombinants. Seroreactive regions of the proteins derived from the E4, E6, E7 (two regions) and L1 (three regions) open reading frames could be found by this approach. Of these seven regions, four were defined by at least two overlapping inserts, thus limiting the domains to between 10 and 15 amino acids. In the case of the E4 open reading frame, the same region identified by immunoscreening was also found when synthetic overlapping octapeptides were tested by ELISA with the anti-E4 antiserum. Using an approach to predict 'receptor-like' regions within the respective proteins, five of the seven regions were also identified. From the data on these regions, synthetic peptides were produced and used for the detection of antibodies against HPV-16 proteins in human sera by ELISA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701482     DOI: 10.1099/0022-1317-71-11-2709

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.

Authors:  C Bleul; M Müller; R Frank; H Gausepohl; U Koldovsky; H N Mgaya; J Luande; M Pawlita; J ter Meulen; R Viscidi
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

2.  Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses.

Authors:  L Dillner; P Heino; J Moreno-Lopez; J Dillner
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

Review 3.  Pathogenesis of genital HPV infection.

Authors:  A Schneider
Journal:  Genitourin Med       Date:  1993-06

4.  A prospective study of antibody responses to defined epitopes of human papillomavirus (HPV) type 16 in relationship to genital and anorectal presence of HPV DNA.

Authors:  G J Van Doornum; M Prins; L Pronk; R A Coutinho; J Dillner
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

5.  Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation.

Authors:  M C Stöppler; K Ching; H Stöppler; K Clancy; R Schlegel; J Icenogle
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

6.  Antibodies to human papillomavirus type 16 E7 related to clinicopathological data in patients with cervical carcinoma.

Authors:  M F Baay; J M Duk; M P Burger; J Walboomers; J ter Schegget; K H Groenier; H W de Bruijn; E Stolz; P Herbrink
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

7.  Comparison of peptide enzyme-linked immunosorbent assay and radioimmunoprecipitation assay with in vitro-translated proteins for detection of serum antibodies to human papillomavirus type 16 E6 and E7 proteins.

Authors:  Y Sun; K V Shah; M Müller; N Muñoz; X F Bosch; R P Viscidi
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

8.  New Approaches to Immunotherapy for HPV Associated Cancers.

Authors:  Anne-Sophie Bergot; Andrew Kassianos; Ian H Frazer; Deepak Mittal
Journal:  Cancers (Basel)       Date:  2011-09-02       Impact factor: 6.639

9.  Validation of Serological Antibody Profiles Against Human Papillomavirus Type 16 Antigens as Markers for Early Detection of Cervical Cancer.

Authors:  Dolores Azucena Salazar-Piña; Adolfo Pedroza-Saavedra; Aurelio Cruz-Valdez; Eduardo Ortiz-Panozo; Minerva Maldonado-Gama; Lilia Chihu-Amparan; Angelica Nallelhy Rodriguez-Ocampo; Emilia Orozco-Fararoni; Fernando Esquivel-Guadarrama; Lourdes Gutierrez-Xicotencatl
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.